ADAR1 Capital Management, LLC
In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 14, 2024), ADAR1 Capital Management, LLC reported 244 stock positions worth $596.5 million. Its top holding was Cytokinetics (CYTK) at 8.1% of the portfolio, followed by Protagonist Therapeutics (PTGX, 7.4%) and Bridgebio Pharma (BBIO, 6.2%). Compared with Q2 2024, it opened 80 new positions, sold out of 67, added to 75 and reduced 68. The biggest buy was Immunovant (IMVT, shares +137%) and the biggest sale Protagonist Therapeutics (PTGX, shares −39%).
- Most Recent 13F
- Q2 2026
- Location
- AUSTIN, TX
- CIK
- 0001940272
- Portfolio Value
- $596.5M (Q3 2024)
- SEC Filing
- 0001940267-24-000005 ↗ filed Nov 14, 2024
Holdings Value
Holdings 244 stocks · $596.5M
| CYTK Cytokinetics Inc. | 8.07% | 911,182 | $48.1M | Add +6.7% |
| PTGX Protagonist Therapeutics Inc. | 7.40% | 981,295 | $44.2M | Reduce -38.8% |
| BBIO Bridgebio Pharma Inc. | 6.18% | 1,448,470 | $36.9M | Add +14.5% |
| BOXX Alpha Architect 1-3 MNTH Box | 5.91% | 323,382 | $35.2M | Reduce -8.0% |
| ROIV Roivant Sciences Ltd. | 5.85% | 3,025,450 | $34.9M | Reduce -27.1% |
| IMVT Immunovant Inc. | 5.41% | 1,131,707 | $32.3M | Add +137.5% |
| RPRX Royalty Pharma PLC Class A | 5.20% | 1,096,666 | $31.0M | Reduce -7.2% |
| KROS Keros Therapeutics Inc. | 4.33% | 445,068 | $25.8M | Reduce -18.9% |
| ASND Ascendis Pharma A/S | 4.04% | 161,402 | $24.1M | Add +214.8% |
| ZURA Zura Bio Ltd. | 2.57% | 3,770,649 | $15.3M | New |
| ZLAB Zai Lab Ltd.-ADR | 2.15% | 532,454 | $12.9M | Add +2320.3% |
| KNSA Kiniksa Pharmaceuticals Inte | 1.83% | 436,668 | $10.9M | Add +282.0% |
| AAM Aa Mission Acquisition Cor-A | 1.70% | 1,010,199 | $10.1M | New |
| MLYS Mineralys Therapeutics Inc. | 1.48% | 729,401 | $8.8M | Add +2775.5% |
| ABUS Arbutus Biopharma Corp. | 1.35% | 2,089,321 | $8.0M | Reduce -36.5% |
| SLDB Solid Biosciences Inc. | 1.34% | 1,145,592 | $8.0M | Reduce -19.4% |
| MRUS Merus NV | 1.28% | 153,286 | $7.7M | Add +470.9% |
| RZLT Rezolute Inc. | 1.28% | 1,571,705 | $7.6M | Reduce -23.9% |
| FRNM Freenome Inc. filed as PERCEPTIVE CAP SOLUTIONS COR | 1.26% | 750,000 | $7.5M | No change |
| XNCR Xencor Inc. | 1.15% | 342,262 | $6.9M | New |
| SNDX Syndax Pharmaceuticals Inc. | 1.13% | 350,206 | $6.7M | New |
| ANAB Anaptysbio Inc. | 1.08% | 192,720 | $6.5M | Add +23.7% |
| ABVX Abivax SA-ADR | 1.01% | 521,612 | $6.0M | Add +1831.9% |
| RGNX Regenxbio Inc. | 1.00% | 569,008 | $6.0M | Add +20974.4% |
| BIIB Biogen Inc. | 0.96% | 29,625 | $5.7M | New |
| OABI Omniab Inc. | 0.95% | 1,337,302 | $5.7M | Add +87.7% |
| CGON CG Oncology Inc. | 0.91% | 143,104 | $5.4M | Add +1013.6% |
| CRNX Crinetics Pharmaceuticals Inc. | 0.76% | 88,425 | $4.5M | Add +18.1% |
| BBOT Bridgebio Oncology Therapeut filed as HELIX ACQUISITION CORP II | 0.71% | 404,138 | $4.2M | No change |
| TECX Tectonic Therapeutic Inc. | 0.65% | 127,159 | $3.9M | Reduce -64.4% |
| ITOS Iteos Therapeutics Inc. | 0.64% | 376,737 | $3.8M | Add +527.9% |
| ABSI Absci Corp. | 0.64% | 1,005,750 | $3.8M | Reduce -40.8% |
| EDR Endeavor Group Hold Class A | 0.59% | 122,807 | $3.5M | Add +1056.9% |
| APGE Apogee Therapeutics Inc. | 0.56% | 57,183 | $3.4M | Add +39.9% |
| DNTH Dianthus Therapeutics Inc. | 0.55% | 118,738 | $3.3M | New |
| SVRA Savara Inc. | 0.53% | 742,634 | $3.1M | Add +11.9% |
| DNLI Denali Therapeutics Inc. | 0.50% | 101,826 | $3.0M | Add +168.0% |
| GRCE Grace Therapeutics Inc. filed as ACASTI PHARMA INC | 0.48% | 959,571 | $2.9M | New |
| QTTB Q32 Bio Inc. | 0.48% | 64,245 | $2.9M | Reduce -59.0% |
| PLRX Pliant Therapeutics Inc. | 0.46% | 246,128 | $2.8M | Add +2361.3% |
| GERN Geron Corp. | 0.42% | 557,159 | $2.5M | Add +519.1% |
| PIERIS PHARMACEUTICALS INC | 0.40% | 144,641 | $2.4M | New |
| VIR Vir Biotechnology Inc. | 0.40% | 319,185 | $2.4M | Add +190.2% |
| CLRB Cellectar Biosciences Inc. | 0.37% | 1,022,161 | $2.2M | Add +49.9% |
| ALKS Alkermes PLC | 0.35% | 74,431 | $2.1M | Reduce -62.1% |
| RVMD Revolution Medicines Inc. | 0.34% | 44,351 | $2.0M | New |
| BIL SS SPDR BB 1-3M T-Bill ETF | 0.34% | 21,786 | $2.0M | Reduce -33.0% |
| ALEC Alector Inc. | 0.34% | 428,802 | $2.0M | Add +119.5% |
| TEVA Teva Pharmaceutical-SP ADR | 0.33% | 108,171 | $1.9M | Add +4.9% |
| KALA Kala Bio Inc. | 0.29% | 306,067 | $1.7M | No change |
| KRRO Korro Bio Inc. | 0.28% | 49,451 | $1.7M | Add +585.9% |
| ALDX Aldeyra Therapeutics Inc. | 0.27% | 302,212 | $1.6M | New |
| TIL Instil Bio Inc. | 0.27% | 23,707 | $1.6M | New |
| ARES ACQUISITION CORP II | 0.25% | 138,966 | $1.5M | New |
| BNTX Biontech SE-ADR | 0.20% | 10,000 | $1.2M | New |
| MLTX Moonlake Immunotherapeutics | 0.20% | 23,457 | $1.2M | Add +388.7% |
| NVNO Envveno Medical Corporation | 0.20% | 348,263 | $1.2M | Add +72.6% |
| PCVX Vaxcyte Inc. | 0.19% | 10,097 | $1.2M | Reduce -17.6% |
| IRON Disc Medicine Inc. | 0.19% | 22,564 | $1.1M | New |
| XENE Xenon Pharmaceuticals Inc. | 0.18% | 27,903 | $1.1M | Add +493.7% |
| BEAM Beam Therapeutics Inc. | 0.18% | 43,900 | $1.1M | Reduce -39.7% |
| NUVL Nuvalent Inc. Class A | 0.18% | 10,442 | $1.1M | New |
| CTMX Cytomx Therapeutics Inc. | 0.18% | 903,959 | $1.1M | Add +58.0% |
| AVDL Avadel Pharmaceuticals Ltd. | 0.18% | 80,900 | $1.1M | New |
| IBIO Ibio Inc. | 0.18% | 476,212 | $1.1M | Reduce -16.4% |
| PFE Pfizer Inc. | 0.17% | 35,950 | $1.0M | Reduce -10.0% |
| EXAS Exact Sciences Corp. | 0.17% | 15,200 | $1.0M | Add +2433.3% |
| KZR Kezar Life Sciences Inc. | 0.17% | 1,338,273 | $1.0M | New |
| BCAX Bicara Therapeutics Inc. | 0.17% | 40,440 | $1.0M | New |
| ATXS Astria Therapeutics Inc. | 0.17% | 93,284 | $1.0M | Reduce -32.5% |
| LLY Eli Lilly & Co. | 0.17% | 1,150 | $1.0M | New |
| SPRO Spero Therapeutics Inc. | 0.17% | 743,459 | $996K | Reduce -19.1% |
| ITCI Intra-Cellular Therapies Inc. | 0.16% | 13,400 | $980K | New |
| AGIO Agios Pharmaceuticals Inc. | 0.16% | 21,300 | $946K | New |
| RVNC Revance Therapeutics Inc. | 0.16% | 182,166 | $945K | New |
| MIRM Mirum Pharmaceuticals Inc. | 0.16% | 24,100 | $940K | New |
| REGN Regeneron Pharmaceuticals | 0.15% | 871 | $916K | New |
| MCK McKesson Corp. | 0.15% | 1,850 | $915K | New |
| CGEM Cullinan Therapeutics Inc. | 0.15% | 54,358 | $910K | Add +2.1% |
| SRPT Sarepta Therapeutics Inc. | 0.15% | 7,100 | $887K | Add +59.5% |
| TARS Tarsus Pharmaceuticals Inc. | 0.14% | 25,900 | $852K | New |
| CLYM Climb Bio Inc. filed as ELIEM THERAPEUTICS INC | 0.14% | 163,443 | $832K | Add +67.3% |
| ANSC Agriculture & Natural Soluti | 0.14% | 80,362 | $832K | New |
| AGR Avangrid Inc. | 0.14% | 23,000 | $823K | No change |
| KVAUF Keen Vision Acquisition Corp. | 0.13% | 75,000 | $805K | No change |
| PTCT PTC Therapeutics Inc. | 0.12% | 20,000 | $742K | New |
| DAWN Day One Biopharmaceuticals I | 0.12% | 53,111 | $740K | Add +51.3% |
| CNTX Context Therapeutics Inc. | 0.12% | 373,835 | $733K | Reduce -42.1% |
| SLN Silence Therapeutics PLC-ADR | 0.12% | 40,290 | $732K | No change |
| KPRX Kiora Pharmaceuticals Inc. | 0.12% | 196,551 | $719K | Add +13.9% |
| AMLX Amylyx Pharmaceuticals Inc. | 0.12% | 220,906 | $716K | Add +105.9% |
| PWSC Powerschool Holdings Inc. Class A | 0.11% | 30,000 | $684K | New |
| AKRO Akero Therapeutics Inc. | 0.11% | 23,007 | $660K | Reduce -9.8% |
| AURA Aura Biosciences Inc. | 0.11% | 73,663 | $656K | Reduce -63.8% |
| NETD Nabors Energy Transition C-A | 0.11% | 59,900 | $639K | New |
| OPCH Option Care Health Inc. | 0.10% | 20,000 | $626K | Add +66.7% |
| JANX Janux Therapeutics Inc. | 0.10% | 13,000 | $591K | Add +64.7% |
| KURA Kura Oncology Inc. | 0.10% | 30,000 | $586K | New |
| TMTC TMT Acquisition Corp. Class A | 0.09% | 50,000 | $562K | No change |
| KYMR Kymera Therapeutics Inc. | 0.09% | 11,856 | $561K | Reduce -76.6% |
Options reported separately and not counted above: APLT calls ($4.5M), XBI puts ($4.0M), NVO puts ($2.4M), SNDX calls ($2.0M), MCK calls ($1.5M), NVO calls ($1.2M), CYTK calls ($797K), AKRO calls ($646K), BMRN calls ($351K), IMVT calls ($291K), RGNX calls ($187K), TARS calls ($164K), and 8 more.
Other holdings (14): bonds, preferreds, convertibles and warrants · $75K (not counted above)
| Security | Class | Shares / Principal | Value | Change |
|---|---|---|---|---|
| AAM.WS Aa Mission Acquisition -30 | *W EXP 08/01/203 | 505,099 | $30K | New |
| GLSTR Global Star Acquisition-RTS | RIGHT 99/99/9999 | 88,560 | $12K | Reduce -25.2% |
| TMTCR TMT Acquisition Corp.-RT | RIGHT 03/27/2028 | 37,100 | $10K | Reduce -25.6% |
| JVSAR Jvspac Acquisition Corp.-RTS | RIGHT 11/26/2026 | 30,000 | $8K | New |
| IROHR Iron Horse Acquisitions Righ | RIGHT 99/99/9999 | 25,000 | $4K | New |
| BKHAR Black Hawk Acquisition C-RTS | RIGHT 06/20/2025 | 3,000 | $3K | New |
| GLSTW Global Star Acquisition-27 A | *W EXP 07/15/202 | 120,000 | $2K | No change |
| EMCRF Embrace Change Acq-Rights | RIGHT 10/25/2026 | 13,144 | $1K | Reduce -27.0% |
| AITRR AI Transportation Acquis-RTS | RIGHT 09/01/2028 | 7,500 | $1K | New |
| UCFIW Iron Horse Acquisition Co.-29 | *W EXP 09/30/203 | 25,000 | $768 | New |
| FTIIW Futuretech II Acq -CW27 | *W EXP 08/18/202 | 30,000 | $762 | No change |
| AIMWF Aimfinity Investment-CW27 | *W EXP 99/99/999 | 18,000 | $362 | No change |
| EMCWF Embrace Change Acquisitio-26 | *W EXP 10/25/202 | 18,000 | $265 | No change |
| MKDWW MKD Tech Inc. -29 | *W EXP 06/10/202 | 3,270 | $60 | New |
Total filed on the 13F, all lines: $596.5M.
Portfolio Sells Q2 2024 → Q3 2024
| PTGX Protagonist Therapeutics Inc. | Reduce -38.8% | 7.40% | −3.79 |
| ROIV Roivant Sciences Ltd. | Reduce -27.1% | 5.85% | −2.98 |
| MRK Merck & Co. Inc. | Reduce -98.5% | 0.02% | −1.87 |
| BOXX Alpha Architect 1-3 MNTH Box | Reduce -8.0% | 5.91% | −1.73 |
| EWTX Edgewise Therapeutics Inc. | Reduce -95.8% | 0.08% | −1.50 |
| QURE Uniqure NV | Sold out | 0.00% | −1.10 |
| RPRX Royalty Pharma PLC Class A | Reduce -7.2% | 5.20% | −1.07 |
| VKTX Viking Therapeutics Inc. | Reduce -92.2% | 0.08% | −0.90 |
| CERE Cerevel Therapeutics Holding | Sold out | 0.00% | −0.77 |
| KROS Keros Therapeutics Inc. | Reduce -18.9% | 4.33% | −0.72 |
| ABUS Arbutus Biopharma Corp. | Reduce -36.5% | 1.35% | −0.70 |
| ALKS Alkermes PLC | Reduce -62.1% | 0.35% | −0.60 |
| ACASTI PHARMA INC | Sold out | 0.00% | −0.56 |
| VUSB Vanguard Ultra Short Bond Et | Sold out | 0.00% | −0.55 |
| JPST JPMorgan Ultra-Short Income | Sold out | 0.00% | −0.55 |
| SHV iShares 0-1 Year Treasury Bo | Sold out | 0.00% | −0.55 |
| TECX Tectonic Therapeutic Inc. | Reduce -64.4% | 0.65% | −0.54 |
| INSM Insmed Inc. | Reduce -91.4% | 0.04% | −0.53 |
| ACHV Achieve Life Sciences Inc. | Reduce -100.0% | 0.00% | −0.51 |
| RZLT Rezolute Inc. | Reduce -23.9% | 1.28% | −0.51 |
| USFR Wisdomtree Floating Rate Tre | Reduce -81.1% | 0.08% | −0.45 |
| FULC Fulcrum Therapeutics Inc. | Reduce -84.8% | 0.03% | −0.43 |
| ABSI Absci Corp. | Reduce -40.8% | 0.64% | −0.41 |
| CNTA Centessa Pharmaceuticals Ltd. | Reduce -90.8% | 0.06% | −0.40 |
| ULST SS Ultra Short TM Bond ETF | Sold out | 0.00% | −0.39 |
| APLT Applied Therapeutics Inc. | Reduce -97.3% | 0.01% | −0.29 |
| DCTH Delcath Systems Inc. | Reduce -84.3% | 0.05% | −0.29 |
| SLDB Solid Biosciences Inc. | Reduce -19.4% | 1.34% | −0.28 |
| ONC Beone Medicines Ltd.-ADR | Reduce -91.2% | 0.04% | −0.28 |
| BIL SS SPDR BB 1-3M T-Bill ETF | Reduce -33.0% | 0.34% | −0.27 |
| SLNO Soleno Therapeutics Inc. | Reduce -75.0% | 0.08% | −0.24 |
| KYMR Kymera Therapeutics Inc. | Reduce -76.6% | 0.09% | −0.21 |
| AURA Aura Biosciences Inc. | Reduce -63.8% | 0.11% | −0.20 |
| GH Guardant Health Inc. | Sold out | 0.00% | −0.20 |
| ANGO Angiodynamics Inc. | Sold out | 0.00% | −0.18 |
| BEAM Beam Therapeutics Inc. | Reduce -39.7% | 0.18% | −0.16 |
| CATX Perspective Therapeutics Inc. | Sold out | 0.00% | −0.14 |
| INDV Indivior Ltd. | Reduce -22.8% | 0.09% | −0.14 |
| CNTX Context Therapeutics Inc. | Reduce -42.1% | 0.12% | −0.14 |
| KEZAR LIFE SCIENCES INC | Sold out | 0.00% | −0.13 |
| VXRT Vaxart Inc. | Sold out | 0.00% | −0.13 |
| CTVA Corteva Inc. | Sold out | 0.00% | −0.12 |
| ARYD Arya Sciences Acquisition-A | Sold out | 0.00% | −0.12 |
| XAIR Beyond Air Inc. | Reduce -77.0% | 0.02% | −0.11 |
| TH Target Hospitality Corp. | Reduce -42.1% | 0.09% | −0.11 |
| ATNM Actinium Pharmaceuticals Inc. | Sold out | 0.00% | −0.11 |
| RYTM Rhythm Pharmaceuticals Inc. | Sold out | 0.00% | −0.11 |
| SYRE Spyre Therapeutics Inc. | Reduce -64.3% | 0.06% | −0.10 |
| YEAR AB Ultra Short Income ETF | Sold out | 0.00% | −0.10 |
| PULS Pgim Ultra Short Bond ETF | Sold out | 0.00% | −0.10 |
Portfolio Buys Q2 2024 → Q3 2024
| IMVT Immunovant Inc. | Add +137.5% | 5.41% | +2.88 |
| ASND Ascendis Pharma A/S | Add +214.8% | 4.04% | +2.63 |
| ZURA Zura Bio Ltd. | New | 2.57% | +2.57 |
| ZLAB Zai Lab Ltd.-ADR | Add +2320.3% | 2.15% | +2.08 |
| AAM Aa Mission Acquisition Cor-A | New | 1.70% | +1.70 |
| MLYS Mineralys Therapeutics Inc. | Add +2775.5% | 1.48% | +1.42 |
| KNSA Kiniksa Pharmaceuticals Inte | Add +282.0% | 1.83% | +1.40 |
| XNCR Xencor Inc. | New | 1.15% | +1.15 |
| SNDX Syndax Pharmaceuticals Inc. | New | 1.13% | +1.13 |
| RGNX Regenxbio Inc. | Add +20974.4% | 1.00% | +0.99 |
| MRUS Merus NV | Add +470.9% | 1.28% | +0.96 |
| BIIB Biogen Inc. | New | 0.96% | +0.96 |
| ABVX Abivax SA-ADR | Add +1831.9% | 1.01% | +0.94 |
| CGON CG Oncology Inc. | Add +1013.6% | 0.91% | +0.82 |
| DNTH Dianthus Therapeutics Inc. | New | 0.55% | +0.55 |
| EDR Endeavor Group Hold Class A | Add +1056.9% | 0.59% | +0.53 |
| GRCE Grace Therapeutics Inc. | New | 0.48% | +0.48 |
| ITOS Iteos Therapeutics Inc. | Add +527.9% | 0.64% | +0.47 |
| PLRX Pliant Therapeutics Inc. | Add +2361.3% | 0.46% | +0.44 |
| OABI Omniab Inc. | Add +87.7% | 0.95% | +0.41 |
| PIERIS PHARMACEUTICALS INC | New | 0.40% | +0.40 |
| GERN Geron Corp. | Add +519.1% | 0.42% | +0.35 |
| RVMD Revolution Medicines Inc. | New | 0.34% | +0.34 |
| DNLI Denali Therapeutics Inc. | Add +168.0% | 0.50% | +0.32 |
| ANAB Anaptysbio Inc. | Add +23.7% | 1.08% | +0.30 |
| ALDX Aldeyra Therapeutics Inc. | New | 0.27% | +0.27 |
| TIL Instil Bio Inc. | New | 0.27% | +0.27 |
| ARES ACQUISITION CORP II | New | 0.25% | +0.25 |
| APGE Apogee Therapeutics Inc. | Add +39.9% | 0.56% | +0.24 |
| KRRO Korro Bio Inc. | Add +585.9% | 0.28% | +0.23 |
| VIR Vir Biotechnology Inc. | Add +190.2% | 0.40% | +0.20 |
| BNTX Biontech SE-ADR | New | 0.20% | +0.20 |
| IRON Disc Medicine Inc. | New | 0.19% | +0.19 |
| NUVL Nuvalent Inc. Class A | New | 0.18% | +0.18 |
| AVDL Avadel Pharmaceuticals Ltd. | New | 0.18% | +0.18 |
| KZR Kezar Life Sciences Inc. | New | 0.17% | +0.17 |
| BCAX Bicara Therapeutics Inc. | New | 0.17% | +0.17 |
| LLY Eli Lilly & Co. | New | 0.17% | +0.17 |
| EXAS Exact Sciences Corp. | Add +2433.3% | 0.17% | +0.17 |
| ITCI Intra-Cellular Therapies Inc. | New | 0.16% | +0.16 |
| AGIO Agios Pharmaceuticals Inc. | New | 0.16% | +0.16 |
| RVNC Revance Therapeutics Inc. | New | 0.16% | +0.16 |
| MIRM Mirum Pharmaceuticals Inc. | New | 0.16% | +0.16 |
| ALEC Alector Inc. | Add +119.5% | 0.34% | +0.16 |
| MLTX Moonlake Immunotherapeutics | Add +388.7% | 0.20% | +0.16 |
| REGN Regeneron Pharmaceuticals | New | 0.15% | +0.15 |
| MCK McKesson Corp. | New | 0.15% | +0.15 |
| XENE Xenon Pharmaceuticals Inc. | Add +493.7% | 0.18% | +0.15 |
| TARS Tarsus Pharmaceuticals Inc. | New | 0.14% | +0.14 |
| ANSC Agriculture & Natural Soluti | New | 0.14% | +0.14 |
Options Activity Q2 2024 → Q3 2024
| INSM Insmed Inc. | put | Sold out | 200,800 | $13.5Mbefore exit |
| INSM Insmed Inc. | call | Sold out | 150,000 | $10.1Mbefore exit |
| APLT Applied Therapeutics Inc. | call | New | 530,200 | $4.5M |
| SPY SS SPDR S&P 500 ETF Trust-US | put | Sold out | 8,000 | $4.4Mbefore exit |
| XBI SS SPDR S&P Biotech ETF | put | New | 40,000 | $4.0M |
| NVO Novo-Nordisk A/S-Spons ADR | put | New | 20,000 | $2.4M |
| CERE Cerevel Therapeutics Holding | put | Sold out | 50,200 | $2.1Mbefore exit |
| SNDX Syndax Pharmaceuticals Inc. | call | New | 105,000 | $2.0M |
| MCK McKesson Corp. | call | New | 3,000 | $1.5M |
| QQQ Invesco QQQ Trust Series 1 | put | Sold out | 3,000 | $1.4Mbefore exit |
| NVO Novo-Nordisk A/S-Spons ADR | call | New | 10,000 | $1.2M |
| CYTK Cytokinetics Inc. | call | Add +15000.0% | 15,100 | $797K |
| AKRO Akero Therapeutics Inc. | call | New | 22,500 | $646K |
| IWM iShares Russell 2000 ETF | put | Sold out | 3,000 | $609Kbefore exit |
| MRNA Moderna Inc. | call | Sold out | 5,000 | $594Kbefore exit |
| BMRN Biomarin Pharmaceutical Inc. | call | New | 5,000 | $351K |
| IMVT Immunovant Inc. | call | New | 10,200 | $291K |
| RGNX Regenxbio Inc. | call | New | 17,800 | $187K |
| TARS Tarsus Pharmaceuticals Inc. | call | New | 5,000 | $164K |
| GALT Galectin Therapeutics Inc. | put | New | 55,300 | $152K |
| CAPR Capricor Therapeutics Inc. | put | Sold out | 20,400 | $97Kbefore exit |
| BBIO Bridgebio Pharma Inc. | call | Sold out | 3,700 | $94Kbefore exit |
| SAGE Sage Therapeutics Inc. | call | New | 9,500 | $69K |
| FULC Fulcrum Therapeutics Inc. | call | Reduce -25.0% | 15,000 | $54K |
| SVRA Savara Inc. | put | Sold out | 11,000 | $44Kbefore exit |
| GLYCOMIMETICS INC | put | Sold out | 135,000 | $38Kbefore exit |
| ANAB Anaptysbio Inc. | call | Sold out | 1,500 | $38Kbefore exit |
| BBIO Bridgebio Pharma Inc. | put | Sold out | 1,200 | $30Kbefore exit |
| TGTX TG Therapeutics Inc. | put | New | 1,000 | $23K |
| SVRA Savara Inc. | call | Sold out | 5,000 | $20Kbefore exit |
| KROS Keros Therapeutics Inc. | call | New | 300 | $17K |
| EQ Equillium Inc. | call | Sold out | 8,800 | $6Kbefore exit |
| AEROVATE THERAPEUTICS INC | call | Sold out | 2,500 | $4Kbefore exit |
| APLS Apellis Pharmaceuticals Inc. | call | Sold out | 100 | $4Kbefore exit |
| ANRO Alto Neuroscience Inc. | put | New | 100 | $1K |
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
Notes & Other Activity Q2 2024 → Q3 2024
| AAM.WS Aa Mission Acquisition -30 | *W EXP 08/01/203 | New | 505,099 | $30K |
| GLSTR Global Star Acquisition-RTS | RIGHT 99/99/9999 | Reduce -25.2% | 88,560 | $12K |
| TMTCR TMT Acquisition Corp.-RT | RIGHT 03/27/2028 | Reduce -25.6% | 37,100 | $10K |
| JVSAR Jvspac Acquisition Corp.-RTS | RIGHT 11/26/2026 | New | 30,000 | $8K |
| OAKUR Oak Woods Acquisition Cor-RT | RIGHT 03/23/2028 | Sold out | 30,000 | $8Kbefore exit |
| IROHR Iron Horse Acquisitions Righ | RIGHT 99/99/9999 | New | 25,000 | $4K |
| BKHAR Black Hawk Acquisition C-RTS | RIGHT 06/20/2025 | New | 3,000 | $3K |
| EMCRF Embrace Change Acq-Rights | RIGHT 10/25/2026 | Reduce -27.0% | 13,144 | $1K |
| CETUR Cetus Capital Acquisition Co. | RIGHT 03/31/2024 | Sold out | 4,999 | $1Kbefore exit |
| SBCWW Pono Capital Two Inc. -27 | *W EXP 09/17/202 | Sold out | 19,800 | $1Kbefore exit |
| AITRR AI Transportation Acquis-RTS | RIGHT 09/01/2028 | New | 7,500 | $1K |
| UCFIW Iron Horse Acquisition Co.-29 | *W EXP 09/30/203 | New | 25,000 | $768 |
| OAKUW Oak Woods Acquisition -28 | *W EXP 99/99/999 | Sold out | 30,000 | $750before exit |
| ECD AUTOMOTIVE DESIGN INC | *W EXP 12/12/202 | Sold out | 32,596 | $652before exit |
| FORLW Four Leaf Acquisition Cor-28 | *W EXP 03/15/202 | Sold out | 7,987 | $360before exit |
| CETUW Cetus Capital Acquisition-28 | *W EXP 01/31/202 | Sold out | 5,000 | $130before exit |
| MKDWW MKD Tech Inc. -29 | *W EXP 06/10/202 | New | 3,270 | $60 |
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 260 | $2.1B | ABVX, PTGX, ROIV, SPY, IMVT |
| Q1 2026 | 290 | $1.6B | ABVX, PTGX, ROIV, IMVT, SPY |
| Q4 2025Amended | 248 | $1.3B | ABVX, PTGX, ROIV, IMVT, RNAM |
| Q3 2025 | 196 | $1.0B | ABVX, KROS, PTGX, ROIV, BOXX |
| Q2 2025 | 192 | $609.1M | KROS, PTGX, BOXX, ZLAB, ABVX |
| Q1 2025 | 185 | $505.1M | PTGX, BOXX, ROIV, ZLAB, IMVT |
| Q4 2024 | 185 | $469.3M | ROIV, PTGX, BOXX, ZLAB, IMVT |
| Q3 2024 | 244 | $596.5M | CYTK, PTGX, BBIO, BOXX, ROIV |
| Q2 2024 | 231 | $496.6M | PTGX, CYTK, ROIV, BOXX, BBIO |
| Q1 2024 | 223 | $366.2M | BOXX, ROIV, ALNY, PTGX, CYTK |